Cutting edge: Suppression of T cell chemotaxis by sphingosine 1-phosphate

被引:114
作者
Graeler, M
Shankar, G
Goetzl, EJ
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Med Ctr, Dept Microbiol Immunol, San Francisco, CA 94143 USA
[3] Ceretek LLC, Alameda, CA 94502 USA
关键词
D O I
10.4049/jimmunol.169.8.4084
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine CD4 and CD8 T cells express predominantly types 1 and 4 sphingosine 1-phosphate (S1P) G protein-coupled receptors (designated S1P1 and S1P4 or previously endothelial differentiation gene-encoded 1 and 6) for S1P, which has a normal plasma concentration of 0.1-1 muM. S1P now is shown to enhance chemotaxis of CD4 T cells to CCL-21 and CCL-5 by up to 2.5-fold at 10 nM to 0.1 muM,whereas 0.3-3 muM S1P inhibits this chemotaxis by up to 70%. Chemotaxis of S1P(1), but not S1P(4), transfectants to CXCL1 and CXCL4 was similarly affected by S1P. Activation of CD4 T cells, which decreases S1P receptor expression, suppressed effects of S1P on chemotaxis. Pretreatment of labeled CD4 T cells with S1P before reintroduction into mice inhibited by a maximum of 75% their migration into chemokine-challenged s.c. air pouches. The S1P-S1P(1) receptor axis thus controls recruitment of naive T cells by maintaining their response threshold to diverse lymphotactic factors.
引用
收藏
页码:4084 / 4087
页数:4
相关论文
共 15 条
[1]   The immune modulator FTY720 targets sphingosine 1-phosphate receptors [J].
Brinkmann, V ;
Davis, MD ;
Heise, CE ;
Albert, R ;
Cottens, S ;
Hof, R ;
Bruns, C ;
Prieschl, E ;
Baumruker, T ;
Hiestand, P ;
Foster, CA ;
Zollinger, M ;
Lynch, KR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :21453-21457
[2]   International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature [J].
Chun, J ;
Goetzl, EJ ;
Hla, T ;
Igarashi, Y ;
Lynch, KR ;
Moolenaar, W ;
Pyne, S ;
Tigyi, G .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :265-269
[3]   A Growing Family of Receptor Genes for Lysophosphatidic Acid (LPA) and other Lysophospholipids (LPs) [J].
Chun J. ;
Contos J.J.A. ;
Munroe D. .
Cell Biochemistry and Biophysics, 1999, 30 (2) :213-242
[4]   Lysophosphatidic acid as a phospholipid mediator: Pathways of synthesis [J].
Gaits, F ;
Fourcade, O ;
LeBalle, F ;
Gueguen, G ;
Gaige, B ;
GassamaDiagne, A ;
Fauvel, J ;
Salles, JP ;
Mauco, G ;
Simon, MF ;
Chap, H .
FEBS LETTERS, 1997, 410 (01) :54-58
[5]   Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate [J].
Goetzl, EJ ;
An, SZ .
FASEB JOURNAL, 1998, 12 (15) :1589-1598
[6]   Cutting edge: Differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes [J].
Goetzl, EJ ;
Kong, Y ;
Voice, JK .
JOURNAL OF IMMUNOLOGY, 2000, 164 (10) :4996-4999
[7]  
GRAELER M, IN PRESS FASEB J
[8]  
HLA T, 1990, J BIOL CHEM, V265, P9308
[9]   Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists [J].
Mandala, S ;
Hajdu, R ;
Bergstrom, J ;
Quackenbush, E ;
Xie, J ;
Milligan, J ;
Thornton, R ;
Shei, GJ ;
Card, D ;
Keohane, C ;
Rosenbach, M ;
Hale, J ;
Lynch, CL ;
Rupprecht, K ;
Parsons, W ;
Rosen, H .
SCIENCE, 2002, 296 (5566) :346-349
[10]   Lysophosphatidic acid: G-protein signalling and cellular responses [J].
Moolenaar, WH ;
Kranenburg, O ;
Postma, FR ;
Zondag, GCM .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :168-173